Oxford, UK – PrecisionLife’s unique AI platform has found 68 genes associated with risk of developing severe COVID-19 after analysis of the genomes of 929 patients from the UK Biobank who had a severe response to SARS-CoV-2.
22 July 2021 Page 8 of Summer Edition 2021 of Thumbprint, the Membership magazine of Motor Neurone Disease Association….22/07/21
8 July 2021 The study undertaken by PrecisionLife and Optum Labs leaders Taryn O. Hall and Kathy T.H. Zheng…8/07/21